Receptor Binding and Pharmacology Models
Learn how receptor binding and pharmacology models describe drug-receptor interactions, affinity, receptor occupancy, efficacy, concentration-effect relationships, and mechanisms of pharmacologic response.
Placebo and Disease Progression Modeling
Learn how placebo response and disease progression models describe baseline disease, natural history, treatment-independent change, placebo effects, and drug effects in clinical pharmacology and PK/PD modeling.
Placebo Response Models
Learn how placebo response models describe changes in clinical outcomes over time, separate placebo and drug effects, and support PK/PD and exposure-response modeling in clinical trials.
Pharmacodynamic Transduction Cascades
Learn how pharmacodynamic transduction cascades connect drug-receptor binding to downstream signaling, amplification, delay, adaptation, and observed drug effects using mechanistic PK/PD models.
Pharmacodynamic Biomarkers and Drug Response
Learn how pharmacodynamic biomarkers quantify drug response, how biomarker changes are linked to drug exposure, and how PK/PD models describe concentration-effect relationships, delays, variability, and dose-response behavior.
Partial Agonism in PK/PD Models
Learn how partial agonism is represented in PK/PD models, including receptor efficacy, Emax relationships, intrinsic activity, concentration-effect curves, and the distinction between affinity and maximal effect.
PK/PD Models with Disease Progression
Learn how PK/PD models incorporate disease progression, natural history, treatment effects, biomarkers, disease-state trajectories, and delayed pharmacodynamic responses.
PK/PD Models for Time-to-Event Outcomes
Learn how PK/PD models can connect drug exposure to time-to-event outcomes, including hazard models, survival probabilities, exposure-response relationships, covariates, and simulation.
PK/PD Models for Ordinal Response
Learn how PK/PD models can describe ordinal pharmacodynamic responses, including proportional-odds models, exposure-response relationships, covariates, interpretation, diagnostics, and prediction.
PK/PD Models for Count Data
Learn how PK/PD models can describe count-based pharmacodynamic endpoints, including Poisson, negative binomial, zero-inflated, and exposure-linked count models.